138 related articles for article (PubMed ID: 16828498)
1. In cis inhibition of antigen processing by the latency-associated nuclear antigen I of Kaposi sarcoma herpes virus.
Zaldumbide A; Ossevoort M; Wiertz EJ; Hoeben RC
Mol Immunol; 2007 Feb; 44(6):1352-60. PubMed ID: 16828498
[TBL] [Abstract][Full Text] [Related]
2. The nested open reading frame in the Epstein-Barr virus nuclear antigen-1 mRNA encodes a protein capable of inhibiting antigen presentation in cis.
Ossevoort M; Zaldumbide A; te Velthuis AJ; Melchers M; Ressing ME; Wiertz EJ; Hoeben RC
Mol Immunol; 2007 Jul; 44(14):3588-96. PubMed ID: 17449101
[TBL] [Abstract][Full Text] [Related]
3. RFHVMn ORF73 is structurally related to the KSHV ORF73 latency-associated nuclear antigen (LANA) and is expressed in retroperitoneal fibromatosis (RF) tumor cells.
Burnside KL; Ryan JT; Bielefeldt-Ohmann H; Gregory Bruce A; Thouless ME; Tsai CC; Rose TM
Virology; 2006 Oct; 354(1):103-15. PubMed ID: 16879850
[TBL] [Abstract][Full Text] [Related]
4. Accumulation of heterochromatin components on the terminal repeat sequence of Kaposi's sarcoma-associated herpesvirus mediated by the latency-associated nuclear antigen.
Sakakibara S; Ueda K; Nishimura K; Do E; Ohsaki E; Okuno T; Yamanishi K
J Virol; 2004 Jul; 78(14):7299-310. PubMed ID: 15220403
[TBL] [Abstract][Full Text] [Related]
5. The Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen binds to specific sequences at the left end of the viral genome through its carboxy-terminus.
Cotter MA; Subramanian C; Robertson ES
Virology; 2001 Dec; 291(2):241-59. PubMed ID: 11878894
[TBL] [Abstract][Full Text] [Related]
6. Identification of B cell epitopes at the C-terminus of latency-associated nuclear protein of the kaposi's sarcoma-associated herpesvirus.
Yao S; Tang Q; Cheng L; Zeng Y; Chen X; Qin D; Lv Z; Lu C
Acta Virol; 2007; 51(2):109-18. PubMed ID: 17900217
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1.
Levitskaya J; Coram M; Levitsky V; Imreh S; Steigerwald-Mullen PM; Klein G; Kurilla MG; Masucci MG
Nature; 1995 Jun; 375(6533):685-8. PubMed ID: 7540727
[TBL] [Abstract][Full Text] [Related]
8. HHV-8 encoded LANA-1 alters the higher organization of the cell nucleus.
Stuber G; Mattsson K; Flaberg E; Kati E; Markasz L; Sheldon JA; Klein G; Schulz TF; Szekely L
Mol Cancer; 2007 Apr; 6():28. PubMed ID: 17433107
[TBL] [Abstract][Full Text] [Related]
9. The 3D structure of Kaposi sarcoma herpesvirus LANA C-terminal domain bound to DNA.
Hellert J; Weidner-Glunde M; Krausze J; Lünsdorf H; Ritter C; Schulz TF; Lührs T
Proc Natl Acad Sci U S A; 2015 May; 112(21):6694-9. PubMed ID: 25947153
[TBL] [Abstract][Full Text] [Related]
10. Physical and functional interactions between STAT3 and Kaposi's sarcoma-associated herpesvirus-encoded LANA.
Muromoto R; Okabe K; Fujimuro M; Sugiyama K; Yokosawa H; Seya T; Matsuda T
FEBS Lett; 2006 Jan; 580(1):93-8. PubMed ID: 16364321
[TBL] [Abstract][Full Text] [Related]
11. Accumulation of LANA at nuclear matrix fraction is important for Kaposi's sarcoma-associated herpesvirus replication in latency.
Ohsaki E; Suzuki T; Karayama M; Ueda K
Virus Res; 2009 Jan; 139(1):74-84. PubMed ID: 19027806
[TBL] [Abstract][Full Text] [Related]
12. KSHV encoded LANA upregulates Pim-1 and is a substrate for its kinase activity.
Bajaj BG; Verma SC; Lan K; Cotter MA; Woodman ZL; Robertson ES
Virology; 2006 Jul; 351(1):18-28. PubMed ID: 16647097
[TBL] [Abstract][Full Text] [Related]
13. The Kaposi Sarcoma Herpesvirus Latency-associated Nuclear Antigen DNA Binding Domain Dorsal Positive Electrostatic Patch Facilitates DNA Replication and Episome Persistence.
Li S; Tan M; Juillard F; Ponnusamy R; Correia B; Simas JP; Carrondo MA; McVey CE; Kaye KM
J Biol Chem; 2015 Nov; 290(47):28084-28096. PubMed ID: 26420481
[TBL] [Abstract][Full Text] [Related]
14. Seroreactivity to Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) latent nuclear antigen in AIDS-associated Kaposi's sarcoma patients depends on CD4+ T-cell count.
de Souza VA; Pierrotti LC; Sumita LM; Freire WS; Segurado AA; Pannuti CS
J Med Virol; 2007 Oct; 79(10):1562-8. PubMed ID: 17705173
[TBL] [Abstract][Full Text] [Related]
15. Poly(ADP-ribose) polymerase 1 binds to Kaposi's sarcoma-associated herpesvirus (KSHV) terminal repeat sequence and modulates KSHV replication in latency.
Ohsaki E; Ueda K; Sakakibara S; Do E; Yada K; Yamanishi K
J Virol; 2004 Sep; 78(18):9936-46. PubMed ID: 15331727
[TBL] [Abstract][Full Text] [Related]
16. Biophysical and mutational analysis of the putative bZIP domain of Epstein-Barr virus EBNA 3C.
West MJ; Webb HM; Sinclair AJ; Woolfson DN
J Virol; 2004 Sep; 78(17):9431-45. PubMed ID: 15308737
[TBL] [Abstract][Full Text] [Related]
17. Kaposi's sarcoma herpesvirus C-terminal LANA concentrates at pericentromeric and peri-telomeric regions of a subset of mitotic chromosomes.
Kelley-Clarke B; Ballestas ME; Komatsu T; Kaye KM
Virology; 2007 Jan; 357(2):149-57. PubMed ID: 16979209
[TBL] [Abstract][Full Text] [Related]
18. Kaposi sarcoma-associated herpesvirus latency-associated nuclear antigen inhibits interferon (IFN) beta expression by competing with IFN regulatory factor-3 for binding to IFNB promoter.
Cloutier N; Flamand L
J Biol Chem; 2010 Mar; 285(10):7208-21. PubMed ID: 20048166
[TBL] [Abstract][Full Text] [Related]
19. The effects of human herpesvirus 8 infection and interferon-gamma response in cutaneous lesions of Kaposi sarcoma differ among human immunodeficiency virus-infected and uninfected individuals.
Guedes F; de Andrade HF; Fernandes ER; Tuon FF; Brasil RA; Pagliari C; Duarte MI
Br J Dermatol; 2008 Sep; 159(4):839-46. PubMed ID: 18644020
[TBL] [Abstract][Full Text] [Related]
20. The glycine-alanine repeating region is the major epitope of the Epstein-Barr nuclear antigen-1 (EBNA-1).
Rumpold H; Rhodes GH; Bloch PL; Carson DA; Vaughan JH
J Immunol; 1987 Jan; 138(2):593-9. PubMed ID: 2432130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
